Material burden refers to the tangible financial and practical costs that affect a person’s ability to maintain their standard of living, access healthcare, or participate in medical research. The term appears most often in two overlapping contexts: the financial strain patients experience from healthcare costs, and the logistical costs research participants face when joining clinical trials. In both cases, material burden is distinguished from psychological or physical burden because it deals specifically with money, time, and resources.
Material Burden in Healthcare
When healthcare researchers talk about material burden, they’re usually describing the real, countable costs that illness and treatment impose on patients and their families. This includes direct out-of-pocket expenses like copays, medication costs, and bills for tests and procedures. It also includes indirect costs that are harder to track but just as damaging: lost income from missed work, travel expenses to reach appointments, and the time care itself demands.
Together, these costs make up what researchers call the “material domain” of financial toxicity. The material domain captures the strain caused by out-of-pocket spending, medical debt, and lost income. It’s one piece of a larger picture that also includes administrative burden (navigating insurance, fighting denied claims) and psychological burden (worry, stress, anxiety about finances). But material burden is the most concrete of the three because it shows up directly in bank accounts, credit reports, and household budgets.
The scale of the problem is significant. State-level data tracked by the State Health Access Data Assistance Center defines high medical cost burden as out-of-pocket health spending (including premiums) exceeding 10 percent of a family’s annual income. For families with low or moderate incomes, this level of spending can quickly spiral into unmanageable debt.
How It Differs From Poverty and Hardship
Material burden overlaps with but isn’t identical to poverty. Poverty describes a lack of financial resources in general. Material hardship, a closely related concept, focuses specifically on lacking goods and services considered necessary for a decent standard of living: adequate food, stable housing, reliable utilities, and basic medical care. You can be above the poverty line and still experience material hardship if a major medical event drains your savings or pushes you into debt.
Research on older adults has shown that material hardship connects directly to both physical and mental health. Studies using national survey data find that people experiencing material hardship report worse self-rated health and more depressive symptoms, including persistent sadness, difficulty sleeping, loneliness, and a feeling that everything requires extra effort. The relationship runs in both directions: poor health creates material burden through medical costs, and material burden worsens health by forcing people to skip medications, delay care, or live in conditions that undermine recovery.
The Effect on Medication Adherence
One of the most studied consequences of material burden is its impact on whether people take their medications as prescribed. In a study of patients managing both type 2 diabetes and high blood pressure, only 23.8 percent of those reporting moderate or high medication-related burden were adherent to their treatment, compared to 42.5 percent of those with minimal burden. After adjusting for other factors, patients with moderate to high burden had 67 percent lower odds of sticking to their medications.
This matters because the medications in question control blood sugar and blood pressure, conditions where skipping doses leads to measurable clinical consequences. The same study found that roughly 30.7 percent of participants reported moderate or high burden, and only 36.8 percent were fully adherent. The cost of pills, the complexity of managing multiple prescriptions, and the logistics of refilling them all contribute to the material weight patients carry.
Material Burden in Clinical Research
The term also applies to research participants. Joining a clinical trial often involves costs that go beyond whatever the study itself covers: transportation to research sites, meals away from home, childcare during appointments, temporary lodging for multi-day visits, and lost wages from time off work. These are the material burdens of participation, and they fall disproportionately on people with fewer resources.
The U.S. Office for Human Research Protections has addressed this directly. Federal advisory recommendations state that reimbursing participants for out-of-pocket costs, including transportation, lodging, childcare, meals, and additional medical expenses, should be considered the “ethical default” whenever study budgets allow. Reimbursement and compensation should also be prorated throughout the study rather than withheld until completion, because making payment contingent on finishing a trial effectively turns reimbursement into a financial incentive that could pressure people into staying enrolled against their better judgment.
This distinction matters for research ethics. If a prospective participant says they feel they “have no choice” but to enroll because of financial need, guidelines recommend providing additional support rather than simply proceeding with enrollment. The goal is to separate the decision to participate from the financial pressures that material burden creates.
How Material Burden Is Measured
Researchers measure material burden in several ways depending on the context. In healthcare, financial toxicity questionnaires ask patients about out-of-pocket spending, debt accumulation, and whether they’ve had to make sacrifices like cutting back on food or other necessities. The material domain is typically separated from administrative burden (time spent on paperwork and insurance) and psychological burden (emotional distress about finances).
In broader social research, material deprivation scales assess whether households can afford items and services considered basic for a decent life. European surveys, for example, use standardized item lists to score how much deprivation a household experiences, with each item chosen because it reliably distinguishes between greater and lesser exposure to hardship. These scales are adapted for different household types, including specific versions that account for whether children are present.
In clinical trials, material burden is typically tracked through expense logs and reimbursement records, capturing costs like travel distance, number of visits, and hours away from work. Institutional review boards evaluate whether these costs are reasonable relative to what participants receive in compensation.
Reducing Material Burden
For patients, the most effective strategies involve financial navigation services offered by hospitals and cancer centers, assistance programs from pharmaceutical companies, and insurance optimization to minimize out-of-pocket exposure. Recognizing material burden early, before it leads to skipped medications or missed appointments, gives healthcare teams a chance to connect patients with resources.
For research participants, ethical guidelines are increasingly clear. Reimbursement for direct costs should be automatic, not something participants have to request. Payments should arrive on a rolling basis throughout the study. And consent processes should include enough time and support for prospective participants to weigh whether the financial demands of a trial are manageable for their situation, including explicit reflection on whether short-term compensation is worth potential long-term risks.